S. Sreenan et al., PREVENTION OF HYPERGLYCEMIA IN THE ZUCKER DIABETIC FATTY RAT BY TREATMENT WITH METFORMIN OR TROGLITAZONE, American journal of physiology: endocrinology and metabolism, 34(4), 1996, pp. 742-747
To determine whether metformin or troglitazone can delay the onset of
diabetes in the Zucker diabetic fatty (ZDF) rat, lean control, fatty,
and ZDF rats received metformin, troglitazone, or no treatment from 6
to 12 wk. of age. Glucose, insulin, triglyceride (TG), and free fatty
acid (FFA) levels and glucose-stimulated insulin secretion by the perf
used pancreas were measured. Metformin-treated rats gained significant
ly less weight. Both drugs prevented hyperglycemia by 12 wk in diabeti
c rats and significantly reduced TG and FFA levels. Insulin secretion
at low glucose was elevated in untreated fatty and diabetic animals, a
nd the increment in diabetic animals produced by glucose perfusion was
attenuated compared with lean and fatty rats. Both drugs reduced basa
l insulin secretion in fatty and diabetic rats and improved glucose re
sponsiveness in diabetic rats. Metformin and troglitazone delay the on
set of diabetes in the ZDF rat. The significantly improved insulin sec
retory response of the pancreas undoubtedly contributes to the improve
d glucose tolerance.